Y-mAbs Therapeutics, Inc. (YMAB)
Sep 15, 2025 - YMAB was delisted (reason: acquired by SERB Pharmaceuticals)
8.61
+0.02 (0.23%)
Inactive · Last trade price on Sep 15, 2025

Y-mAbs Therapeutics Market Cap

Y-mAbs Therapeutics is not actively traded anymore. When Y-mAbs Therapeutics last traded, it had a market cap or net worth of $391.22 million.

Market Cap
391.22M
Enterprise Value
332.06M
1-Year Change
-42.96%
Ranking
Category
Stock Price
$8.61

Market Cap Chart

Since September 21, 2018, Y-mAbs Therapeutics's market cap has decreased from $796.74M to $391.22M, a decrease of -50.90%. That is a compound annual growth rate of -9.68%.

History

DateMarket Cap% Change
Sep 15, 2025391.22M11.56%
Dec 31, 2024350.70M17.88%
Dec 29, 2023297.50M39.61%
Dec 30, 2022213.10M-69.88%
Dec 31, 2021707.47M-64.73%
Dec 31, 2020 Pro Pro
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Sep 21, 2018 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition